Clinical Trial Update: A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients with Cystic Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2b randomized, placebo-controlled trial of OligoG in cystic fibrosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• OligoG (oligoG)

Snippet

Sponsor: AlgiPharma AS | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED